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Abstract
Background: Two types of biaryl crosslinks can be formed
with natural protein sidechains: ditryptophan and dityrosine.
Biaryl crosslinks have the same topology as disulfide cross-
links, yet little is known about their effect on local peptide
structure.
Results : Three ditryptophan-linked peptide dimers based on the
sequence Ac-Leu-Trp-Ala-COX were prepared. The tripeptide
dimer with ^CONH2 termini was too insoluble to study, but the
tripeptide dimer with ^COOMe termini crystallized from meth-
anol/chloroform as an antiparallel L-sheet. The tripeptide di-
mer with a ^CONMe2 termini adopted a slipped antiparallel
L structure in methanol/chloroform.
Conclusions: These results suggest that intermolecular ditrypto-
phan crosslinks that join the middle of peptide chains can confer a
preference for antiparallel L-sheet structure. The effect is most
dramatic when both the inside and outside edges of the dimer can
form hydrogen bonds as in the crystal structure of dimer
3b. ß 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Tryptophan and tyrosine sidechains are subject to oxi-
dative coupling to give £uorescent biaryl crosslinks known
as ditryptophan [1] and dityrosine [2] crosslinks, respec-
tively. The conditions required for ditryptophan and dity-
rosine formation are harsher and less e⁄cient than the
conditions required for disul¢de formation, but unlike cys-
tine disul¢des, there are no simple mechanisms for the
cleavage of biaryl crosslinks [3]. Ditryptophan crosslinks
can have profound e¡ects on local peptide structure. Intra-
molecular ditryptophan crosslinks have been shown to
stabilize Q-turns in tripeptide sequences [4] and a L-turn
in X-indolicidin [5]. Crosslinks generally have detrimental
e¡ects on protein structure and function, and these e¡ects
are probably more important when the crosslinks are per-
sistent.
There are many examples of proteins in which cystine
disul¢des join neighboring strands in the middle of a
L-sheet, and short antiparallel peptides with cystine disul-
¢des at the terminus [6^10], but when placed in the middle
of short peptides, cystine disul¢des are too short to e⁄-
ciently induce L structure [11,12]. One strategy for induc-
ing peptides to adopt antiparallel L conformations is to
put biphenyl [13,14] and bipyridyl [15,16] subunits at the
ends of peptide chains. Peptides have been joined in the
middle through £exible linkers using ole¢n metathesis [17^
19], but it is not clear whether such linkers contribute to
the stability of antiparallel L conformations [20]. Ditryp-
tophans are topologically suited to join antiparallel
L-strands, and long enough to do so in a strain-free man-
ner. The stabilization of antiparallel L-strands by ditryp-
tophans in short-peptide models would provide insight
into their potential e¡ects on protein structure and also
provide the means to create short L-peptide dimers that
could interfere with protein^protein interactions [21,22].
2. Results
2.1. Synthesis of ditryptophan peptide dimers
The simple tripeptide sequence Leu-Trp-Ala was chosen
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as a substrate for ditryptophan crosslinking. Leu-Trp-Ala
is found on the edge of L-sheets in Taq adenine N6-meth-
yltransferase [23] and the capsid protein of bacteriophage
PX174 [24], although ditryptophan crosslinks probably
play no role in the function of these proteins. The tripep-
tide Ac-Leu-Trp-Ala-CONH2, prepared by solid phase
peptide synthesis from Rink amide resin, was subjected
to Mannich dimerization in neat tri£uoroacetic acid, fol-
lowed by oxidative aromatization with DDQ in N-meth-
ylpyrrolidinone to give the £uorescent ditryptophan 1b.
Ditryptophan peptide dimer 1b was reluctant to dissolve
in solvents other than dimethyl formamide (DMF) or di-
methyl sulfoxide (DMSO) (Scheme 1).
A common strategy for preventing aggregation is to
place methyl groups on the edges of peptide chains. This
was easily accomplished by converting the carboxy termi-
nus of Ac-Leu-Trp-Ala-CO2H to the corresponding N,N-
dimethyl amide, followed by Mannich dimerization and
oxidative aromatization to give dimer 2b. The oxidative
aromatization was accomplished with air and light in 9:1
dichloromethane/THF. As an additional strategy for re-
ducing the number of hydrogen-bond donors, the corre-
sponding methyl ester was prepared by solution phase
synthesis of Ac-Leu-Trp-Ala-CO2Me from NK-Boc-tryp-
tophan, followed by the two-step process of ditryptophan
formation. In this case oxidative aromatization was ac-
complished using DDQ. The N,N-dimethylamide peptide
dimer 2b and the methyl ester dimer 3b were soluble in
mixtures of methanol and chloroform, but not neat
chloroform.
2.2. 1H NMR and IR data suggest intramolecular
hydrogen-bonding in dimer 3b
The 1H NMR spectra of peptide dimers 2b and 3b in
1 M CD3OD/CDCl3 were assigned using COSY. None of
the 1H NMR data suggests a preferred conformation for
the ester dimer 3b in 1 M methanol/chloroform. In con-
trast, all of the spectroscopic evidence points to a decisive
conformation for the N,N-dimethylamide dimer 2b. The
half-lives for exchange of the NH protons in the ester
dimer 3b were not substantially di¡erent, but the NH pro-
tons of dimer 2b exhibited dramatic di¡erences in ex-
change rates (Table 1). These e¡ects are consistent with
intramolecular hydrogen bonds to the alanine NHs and
ditryptophan indole NHs in dimer 2b. Stronger hydrogen
bonding should be re£ected in the down¢eld chemical
shifts, and this is observed for the Ala amide NH and
the Trp indole NHs. The Trp indole NH, Ala amide
NH and the Trp amide NH are shifted 2.2, 0.8 and 0.3
ppm down¢eld in the dimer 3b relative to the monomer
3a. In theory, these di¡erences might be attributable to
conformationally induced di¡erences in magnetic anisotro-
py, but concentration e¡ects point to hydrogen bonding:
the amide NH chemical shifts of dimer 2b were invariant
up to the solubility limit of 5 mM, whereas the amide NH
chemical shifts of the monomer 2a varied with concentra-
tion (Fig. 1). Monomers 2a and 3a exhibit an IR stretch
characteristic of a free indole NH (3478 cm31), but dimers
2b and 3b do not (Fig. 2). Either the indole NHs of the
peptide monomers are more resistant to hydrogen bonding
or the biindole NHs of the dimers are more susceptible to
hydrogen bonding.
2.3. Monte Carlo search and ROESY data converge on a
single structure for dimer 2b
Dimer 2b has a molecular weight around 900 and
ROESY is necessary to obtain spatial information. Since
dimer 2b is symmetrical, one can not distinguish intra-
chain ROEs from interchain ROEs. Thus, the ROESY
data can not be used as a distance costraint in a MonteScheme 1.
Table 1
1H exchange rates in 1 M CD3OD/CDCl3
Proton t1=2
dimer 2b (h) dimer 3 (min)
LeuNHK 1 40
TrpNHK 0.5 V35
AlaNHK 9 V35
TrpNH (indole) 8 135
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Carlo conformational search. However, the ROESY data
is powerful for distinguishing between plausible and im-
plausible conformations generated by an unconstrained
Monte Carlo search. These peptide dimers are particularly
suitable for conformational searching because they have
only six amino acids and the central crosslink substantially
reduces the degrees of freedom in the system. Conforma-
tions for dimer 2b were generated with Macromodel v.6.0
using the AMBER* force ¢eld (CHCl3 solvent) starting
from a random, non-L-sheet conformation. AMBER* is
good for peptides, but it underestimates the slight barrier
to ditryptophan planarity predicted by MM2 and AM1 in
Fig. 2b. Thus, conformations with planar ditryptophans
appear more often with AMBER* than with MM2. 1000
Monte Carlo cycles produced 123 unique conformations
with good convergence. Fortunately, all 10 of the lowest
energy conformations, within 4.24 kcal/mol of the global
Fig. 1. Concentration dependence of amide NH shifts in CDCl3.
Fig. 2. Comparison of IR spectrum of (a) monomer 2a (10 mM) vs.
dimer 2b (5 mM) in 1% (v/v) MeOH/CHCl3, and (b) monomer 3a
(9 mM) vs. dimer 3b (4.5 mM) in 1% (v/v) MeOH/CHCl3.
Scheme 2.
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minimum, were nearly identical (Fig. 3). The picture that
emerges for dimer 2b, consistent with all of the spectro-
scopic data, is that the ditryptophan crosslink is holding
the two peptide chains in a slipped antiparallel conforma-
tion, so that two of the four possible L-sheet hydrogen
bonds are realized (Fig. 3). The alanine residues in oppo-
site strands adopt an antiparallel hydrogen-bonded ar-
rangement, consistent with IR and 1H NMR data. The
indole NHs are hydrogen bonded to the leucine carbonyl,
which causes the antiparallel strands to twist downward
from a £at sheet-like orientation. This slipped structure
leaves the leucine and tryptophan amide NHs free to
form intermolecular hydrogen bonds (Scheme 2). This ex-
plains the concentration dependence of their chemical
shifts and why these NHs exchange faster than the corre-
sponding tryptophan indole NH and the alanine amide
NH in 1 M CD3OD/CDCl3.
The ROESY spectrum of dimer 2b was obtained at
6 mM in a solution of 1 M CD3OD/CDCl3 at 30‡C
(400 ms mixing time). Under these conditions, the molar
ratio of deuteromethanol to peptide dimer is about 166:1.
The conformational search and ROESY data converge on
the slipped antiparallel structure (Fig. 4). As expected,
strong crosspeaks were observed for protons that were
separated by fewer than four bonds. However, strong
crosspeaks were also apparent between some non-neigh-
boring protons. Fortunately, the two N-methyl groups
were distinguishable on the ROE time scale. The N-methyl
group with a strong crosspeak to the alanine CKH also
exhibits strong crosspeaks with protons at the 5 and 6
position of the indole ring. The other N-methyl group
has a strong crosspeak to the proton at the 7 position of
the indole ring. Thus, the carboxamide moieties of dimer
2b seem to be positioned over the outer rims of the tryp-
tophan benzene rings. One of the N-methyl groups also
showed a strong NOE to leucine sidechain and the tryp-
tophan CKH as predicted by the slipped structure.
A Monte Carlo search for conformations of the ester
dimer 3b identi¢ed two low energy conformations. One of
them was identical to the slipped L dimer of 2b. The other
conformation was a perfect antiparallel L-sheet with four
intramolecular hydrogen bonds (Fig. 3). A ROESY spec-
trum of the ester dimer 3b in 1 M CD3OD/CDCl3 gener-
ated some, but not all, of the ROEs seen for dimer 2b, but
the ROEs were not of su⁄cient quality or quantity to
provide unambiguous information. It is possible that
dimer 3b may be rapidly (relative to the 1H NMR time
scale) interconverting between a slipped conformation and
an antiparallel conformation in solution.
2.4. Ditryptophan peptide dimer 3b crystallizes as an
antiparallel L-sheet
Attempts were made to generate crystals of all three
ditryptophan peptide dimers, but only the ester dimer 3b
gave X-ray quality crystals. Peptide dimer 3b was crystal-
lized from methanol/dichloromethane. X-ray di¡raction
revealed an antiparallel L-sheet structure partly predicted
by the AMBER*/Monte Carlo search. In the crystal struc-
Fig. 3. Two antiparallel conformations. Unconstrained Monte Carlo searches (AMBER*) predicts two plausible low energy conformations for dimer 3b,
but only one low energy conformation (slipped) for dimer 2b.
Fig. 4. Solution structure of peptide dimer 2b. Diagnostic ROEs are
consistent with the slipped antiparallel L conformation from the Monte
Carlo search. The ditryptophan crosslink is shaded in green.
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ture (Fig. 5), the ditryptophan adopts an S-biaryl con¢g-
uration. Each peptide dimer possesses four intramolecular
hydrogen bonds that polarize the outside edges. Each of
the outside edges engages in the maximum number of
hydrogen bonds, two on each side. The cooperative net-
work of hydrogen bonds that holds this structure together
has the same features as the cooperative networks of hy-
drogen bonds that are essential for the stability of globular
proteins. The crosslinking e¡ect of these hydrogen-bond
networks provides a rationale for the intractability of pep-
tide dimer 1b.
Peptides do not generally crystallize as antiparallel
L-sheets, but a variety of examples are presently known
[25]. For example, Boc-(D)Val-Ala-Leu-Ala-CO2Me crys-
tallizes from aqueous butanol as an extended antiparallel
L-sheet [26]. In addition, +H3N-Ala-Ala-Ala-CO32 crystal-
lizes from aqueous DMF as an antiparallel L-sheet in
which each carboxylate is held in proximity to an ammo-
nium group on an opposing strand [27].
3. Discussion
In conclusion, three ditryptophan-linked peptide dimers
were studied. With a full complement of hydrogen bonds,
the simple ditryptophan peptide dimer 1b was highly in-
soluble. By adding two N-methyl groups to the carboxam-
ide terminus, the resulting peptide dimer 2b was made
tractable. Modeling predicts a single preferred conforma-
tion for dimer 2b and IR, 1H exchange rates and 1H
chemical shifts, and ROEs in methanol/chloroform cor-
roborate the model. In this slipped antiparallel L confor-
mation, the two strands form only two hydrogen bonds.
The peptide backbone of 2b adopts a left-handed twist,
allowing the Leu carbonyl groups to hydrogen bond
with the tryptophan NHs. In contrast, most L-sheets are
curved because extended peptide strands adopt a right-
handed twist due to allylic 1,3 strain [28]. In dimer 3b,
the stability of the slipped structure is probably compro-
mised because the two interstrand hydrogen bonds of 2b,
Fig. 5. Crystal structure of peptide dimer 3b. Top (A) and end (B) views of X-ray crystal structure of the ditryptophan [Ac-Leu-Trp*-Ala-CO2Me]2 3b
showing four unit cells. Leucine and alanine sidechains are rendered in line mode.
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involving amide carbonyls, would be replaced by inter-
strand hydrogen bonds involving ester carbonyls. The sol-
ubility of peptide dimer 3b is better than the carboxamide
analog 1b because it reduces the number of potential hy-
drogen bonds on the outside edge of the antiparallel
L-pleated structure. Recall that the IR data suggests that
the indole NHs of amide dimer 2b and ester dimer 3b were
hydrogen bonded. However, the exchange rates (Table 1)
imply that the indole NHs in dimer 3b hydrogen bond
with less ¢delity, raising the possibility the indole NHs
of dimer 3b may spend some time hydrogen bonding to
the methanol co-solvent.
4. Signi¢cance
The antiparallel L-pleated sheet in the X-ray structure of
dimer 3b is a universal element of protein structure, but
ditryptophans can have even more speci¢c e¡ects. The
twisted conformation induced by the ditryptophan cross-
link in dimer 2b resembles conformations present in a
variety of proteins. Using the program SPASM, similar
peptide conformations were found in the X-ray structures
of proteins MTCP-1 (1A1X), human rhinovirus 16 coat
protein (1AYM), copper amine oxidase (1KSI), neocarzi-
nostatin (1NOA), endo-1,4-L-xylanase (1XYP), sialidase
(3SIL) and the matrix porin outer membrane protein
(2OMF, Fig. 6) [29,30].
Biaryl crosslinks are distinct from disul¢des because
they are highly £uorescent and robust under reducing con-
ditions. Ditryptophan crosslinks were ¢rst reported in
1995, but since that time they have not been identi¢ed in
Nature. However, they appear to provide a promising way
to construct protein-like architectures or peptide biomate-
rials. Since ditryptophans can have such profound e¡ects
on local peptide structure, it seems likely that dityrosine
crosslinks, which occur in all humans, may have analo-
gous consequences. Surprisingly, nothing is known about
the e¡ect of dityrosines on local peptide conformation.
Dityrosines are longer than ditryptophans. If they
span antiparallel L-sheets, then they are more likely to
do so diagonally rather than directly across the peptide
chains.
5. Materials and methods
5.1. Fmoc deprotection
In a solid phase reaction vessel, the Fmoc-resin was suspended
in 1:5 piperdine/DMF (v/v, 50 ml/mmol). The reaction mixture
was agitated by nitrogen bubbling for 1 h. The deprotection so-
lution was forced out under a stream of air and the resin was
dried under a stream of air.
5.2. Coupling with HOBt/HBTU
A solid phase reaction vessel was charged with solid phase
resin with free amino termini. HOBt (3 equiv.) was added, fol-
lowed by Fmoc-amino acid (3 equiv.), HBTU (3 equiv.), dry
DMF (75 ml/mmol) and DIEA (3 equiv.). The solution was agi-
tated by nitrogen bubbling until the Kaiser test indicated the
disappearance of the terminal ^NH2 (about 45 min). The cou-
pling solution was forced out under a stream of air and the resin
was washed with DMF (3U50 ml) and CH2Cl2 (3U50 ml). The
resin was then dried under a stream of air.
5.3. Acetylation of the N-terminus
To the resin-bound peptide in a solid-phase reaction vessel,
pyridine (75 ml), acetic anhydride (5 equiv.), and DMAP
(1 equiv.) were added. The suspended resin was agitated by nitro-
gen bubbling until the Kaiser test indicated the disappearance of
the terminal ^NH2 (45 min). The pyridine solution was £ushed
out of the vessel under the air pressure. The resin-bound peptide
was washed with DMF (3U50 ml) and CH2Cl2 (3U50 ml), and
then dried under a stream of air.
5.4. Resin cleavage
To a solid-phase reaction vessel containing resin from Fmoc
peptide synthesis was added a solution of 81:7:7:3:2 tri£uoro-
acetic acid/phenol/H2O/ethanedithiol/triisopropylsilane (v/v, 75
ml/mmol). The mixture was agitated by nitrogen bubbling for
1 h. The ¢ltrate containing the cleaved, deprotected peptide was
drained from the reaction vessel and the remaining resin was
rinsed with TFA (2U20 ml). The combined ¢ltrates were concen-
trated in vacuo.
5.4.1. AcNH-Leu-Trp*-Ala-NH2
A 500 ml solid-phase reaction vessel was charged with Fmoc-
Rink amide MBHA polystyrene resin (2.00 g, 0.54 mmol/g).
Fig. 6. A related structure from matrix porin outer membrane protein (2OMF.pdb; residues 83^87, 95^99).
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Fmoc deprotection and coupling were carried out iteratively us-
ing the following amino acids (in order): Fmoc-Ala, Fmoc-Trp
and Fmoc-Leu. The peptide was acetylated and cleaved. After the
cleavage step, the peptide was concentrated in vacuo and tritu-
rated with ether (3U50 ml). The solid was taken up in ether (50
ml) and ¢ltered. The precipitate was dried in vacuo and puri¢ed
by silica gel chromatography (10% MeOH/CHCl3) to a¡ord
AcNH-Leu-Trp-Ala-NH2 (0.34 g, 73%) as a white powder.
AcNH-Leu-Trp*-Ala-NH2 : mp 234^236‡C (CHCl3); Rf = 0.26
(10% MeOH/CHCl3); IR (KBr) 3410, 3284, 3063, 2952, 1635,
1539 cm31 ; 1H NMR (400 MHz, DMSO-d6) N 10.83 (s, 1H),
7.99 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.81 (d,
J = 8.0 Hz, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.30 (d, J = 8.0 Hz,
1H), 7.18 (s, 1H), 7.12 (d, J = 4.0 Hz, 1H), 7.05 (t, J = 8.0 Hz,
1H), 7.03 (s, 1H), 6.96 (t, J = 8.0 Hz, 1H), 4.47 (dt, J = 8.0, 4.4
Hz, 1H), 4.18 (m, 2H), 3.15 (dd, J = 14.8, 4.4 Hz, 1H), 2.98 (dd,
J = 14.8, 8.4 Hz, 1H), 1.80 (s, 3H), 1.52 (m, 1H), 1.35 (m, 2H),
1.17 (d, J = 7.2 Hz, 3H), 0.84 (d, J = 6.4 Hz, 3H), 0.79 (d, J = 6.4
Hz, 3H); 13C NMR (125 Hz, DMSO-d6) N 174.1, 172.3, 170.8,
169.6, 136.0, 127.4, 123.6, 120.9, 118.4, 118.3, 111.3, 109.9, 53.3,
51.3, 48.1, 40.4, 27.1, 24.2, 23.0, 22.4, 21.6, 18.3; LRMS (FAB),
m/z (intensity %): 452 (6) [M+Na], 430 (100) [M+H], 413 (23);
HRMS (FAB): calcd for C22H31N5O4, 430.2454 [M+H] ; found
430.2455.
5.4.2. AcNH-Leu-Trp-Ala-OH
A 500 ml solid-phase reaction vessel was charged with Fmoc-
Ala-Wang polystyrene resin (2.3 g, 0.60 mmol/g). Fmoc depro-
tection and HBTU coupling of Fmoc-Trp were carried out using
general procedures. The deprotection and coupling steps were
then repeated for Fmoc-Leu. The N-terminus was acetylated
and the peptide was deprotected and cleaved from the resin.
Puri¢cation of the peptide residue by silica gel chromatography
(1:5:94 AcOH/MeOH/CHCl3) a¡orded AcNH-Leu-Trp-Ala-OH
(0.35 g, 58%) as a white powder.
AcNH-Leu-Trp-Ala-OH: mp 212‡C (CHCl3, dec.) ; Rf = 0.28
(1% AcOH/10% MeOH/CHCl3); IR (KBr) 3417, 3085, 2952,
1628, 1539 cm31 ; 1H NMR (400 MHz, DMSO-d6) N 10.84 (s,
1H), 8.06 (d, J = 7.2 Hz, 1H), 8.04 (d, J = 6.2 Hz, 1H), 7.54 (m,
2H), 7.31 (d, J = 8.0 Hz, 1H), 7.11 (s, 1H), 7.02 (t, J = 7.2 Hz,
1H), 6.95 (t, J = 7.6 Hz, 1H), 4.49 (ddd, J = 7.2, 6.4, 4.8 Hz, 1H),
4.24 (ddd, J = 8.6, 8.4, 5.6 Hz, 1H), 3.98 (m, 1H), 3.20 (dd,
J = 14.8, 4.4 Hz, 1H), 2.96 (dd, J = 14.8, 8.8 Hz, 1H), 1.82 (s,
3H), 1.50 (m, 1H), 1.37 (m, 2H), 1.21 (d, J = 6.8 Hz, 3H), 0.84
(d, J = 6.4 Hz, 3H), 0.79 (d, J = 6.4 Hz, 3H), (CO2-H does not
appear around 12 ppm); 13C NMR (125 MHz, DMSO-d6)
N 176.3, 172.1, 170.0, 169.6, 136.0, 127.4, 123.5, 120.8, 118.4,
118.2, 111.2, 110.2, 53.2, 51.2, 49.5, 40.5, 27.0, 24.2, 23.0, 22.5,
21.5, 18.7; LRMS (FAB), m/z (intensity %): 469 (30) [M+K],
453 (90) [M+Na], 449 (40), 345 (100), 430 (15) [M], 413 (32);
HRMS (FAB): calcd for C22H30N4O5, 453.2114 [M+Na] ;
found 453.2110.
5.4.3. AcNH-Leu-Trp-Ala-NMe2
AcNH-Leu-Trp-Ala-CO2H (260 mg, 0.60 mmol) and dimeth-
ylammonium chloride (59.1 mg, 0.725 mmol) were suspended in
DMF (2 ml). DIPEA (0.32 ml, 1.82 mmol), HOBt (18.5 mg, 0.121
mmol) and HBTU (0.504 g, 1.33 mmol) were added and the
mixture was stirred at room temperature for 21 h. The solvent
was removed in vacuo and the residue was puri¢ed by silica gel
chromatography (5% MeOH/CHCl3) a¡ording AcNH-Leu-Trp-
Ala-NMe2 (0.177 g, 64%) as a yellow solid.
AcNH-Leu-Trp-Ala-NMe2 : mp = 186^187‡C (CHCl3); Rf =
0.34 (10% MeOH/CHCl3); IR (CDCl3) 3478, 3403, 2961, 1644,
1501 cm31 ; 1H NMR (400 MHz, DMSO-d6) N 10.83 (s, 1H), 8.02
(d, J = 8.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 7.6 Hz,
1H), 7.53 (d, J = 8.0, 1H), 7.30 (d, J = 8.4 Hz, 1H), 7.11 (d, J = 2.0
Hz, 1H), 7.04 (t, J = 7.2 Hz, 1H), 6.95 (t, J = 8.0 Hz, 1H), 4.67
(dddd, J = 7.2, 7.2, 6.8, 6.8 Hz, 1H), 4.50 (ddd, J = 8.0, 7.6, 5.2
Hz, 1H), 4.25 (ddd, J = 10.8, 8.8, 4.8 Hz, 1H), 3.11 (dd, J = 14.8,
5.2, Hz, 1H), 2.94 (dd, J = 14.8, 8.4 Hz, 1H), 2.91 (s, 3H), 2.81 (s,
3H), 1.80 (s, 3H), 1.51 (m, 1H), 1.37 (m,2H), 1.13 (d, J = 6.8 Hz,
3H), 0.85 (d, J = 6.4 Hz, 3H), 0.80 (d, J = 6.4 Hz, 3H); 13C NMR
(125 MHz, DMSO-d6) N 172.0, 171.3, 170.4, 169.2, 136.0, 129.3,
123.6, 120.8, 118.4, 118.1, 111.2, 109.8, 53.1, 51.1, 44.5, 40.6,
36.3, 35.2, 27.3, 24.2, 23.0, 22.5, 21.6, 17.5; LRMS (FAB), m/z
(intensity %): 458 (12) [M+H], 307 (26), 289 (7), 170 (5), 154
(100), 136 (74), 124 (15); HRMS (FAB): calcd for C24H35N5O4,
458.2767 [M+H], found 458.2776.
5.4.4. AcNH-Leu-Trp-Ala-OMe
AcNH-Leu-Trp-Ala-OMe was prepared using standard solu-
tion phase peptide synthesis methods using Boc-protected amino
acids.
AcNH-Leu-Trp-Ala-OMe: mp 191^192‡C; Rf = 0.39 (10%
MeOH/CHCl3); IR (KBr) 3412, 3261, 3072, 1743, 1629, 1547,
1459, 1371, 1280, 1215, 746 cm31 ; 1H NMR (500 MHz,
DMSO-d6) N 10.83 (s, 1H), 8.29 (d, J = 7.0 Hz, 1H), 7.94 (d,
J = 7.9 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.56 (d, J = 7.56 Hz,
1H), 7.30 (d, J = 8.0 Hz, 1H), 7.11 (s, 1H), 7.04 (t, J = 7.2 Hz,
1H), 6.96 (t, J = 8.1 Hz, 1H), 4.51 (dd, J = 7.9, 4.8 Hz, 1H), 4.27
(dd, J = 7.2, 7.1 Hz, 1H), 4.21 (m, 1H), 3.62 (s, 3H), 3.12 (dd,
J = 14.7, 10.2 Hz, 1H), 2.94 (dd, J = 14.8, 8.9 Hz, 1H), 1.79 (s,
3H), 1.50 (m, 1H), 1.32 (m, 2H), 1.25 (d, J = 7.2 Hz, 3H), 0.83 (d,
J = 6.5 Hz, 3H), 0.78 (d, J = 6.45 Hz, 3H); 13C NMR (125 MHz,
DMSO-d6) N 172.8, 171.9, 171.2, 169.3, 135.9, 127.4, 123.5, 120.7,
118.3, 118.1, 111.1, 109.8, 52.8, 51.8, 51.1, 47.6, 40.5, 27.4, 24.1,
22.9, 22.4, 21.5, 16.9; LRMS (FAB), m/z (intensity %): 445 (100),
342 (10), 307 (20), 290 (25), 272 (95); HRMS (FAB): calcd for
C23H32N4O5, 444.2373; found 445.2457 [M+H] ; anal. calcd for
C23H32N4O5 : C, 62.13; H, 7.26; N, 12.61; found: C, 62.08; H,
7.26; N, 12.51.
5.4.5. Ditryptophan peptide dimer [AcNH-Leu-Trp*-Ala-NH2]2,
1b
AcNH-Leu-Trp-Ala-NH2 1 (0.192 g, 0.447 mg) was dissolved
in tri£uoroacetic acid (3 ml) and stirred at room temperature for
31 h to promote Mannich crosslinking of the tryptophan side-
chains. The reaction mixture was concentrated in vacuo and sat.
aq. NaHCO3 was added until the solution reached pH 7. The
precipitate was ¢ltered and washed with water (60 ml) and EtOAc
(30 ml), and dried in vacuo. The mixture of tryptophan dimers
was taken on to oxidative aromatization without removing the
left-over peptide monomer.
The residue was dissolved in NMP (2.50 ml), DDQ (19.7 mg,
0.0870 mmol) was added, and the mixture was stirred at room
temperature for 3 h. Aq. NaHCO3 (5 ml, half saturated) was
added and the mixture was stirred for 10 min. The precipitate
was ¢ltered and washed with aq. NaHCO3 (200 ml, half satu-
rated). The residue was puri¢ed by silica gel chromatography
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(10% MeOH/CHCl3) to a¡ord the ditryptophan peptide dimer 1b
(50.3 mg, 26%) as a solid.
1b : mp 277‡C (CHCl3, dec); Rf = 0.20 (10% MeOH/CHCl3);
IR: (KBr) 3394, 2952, 1650, 1524 cm31 ; 1H NMR (500 MHz,
DMSO-d6) N 11.22 (s, 2H), 8.08 (d, J = 7.5 Hz, 2H), 7.99 (d,
J = 8.0 Hz, 2H), 7.78 (d, J = 7.5 Hz, 2H), 7.72 (d, J = 8.0 Hz,
2H), 7.37 (d, J = 8.5 Hz, 2H), 7.13 (t, J = 7.5 Hz, 2H), 7.05 (m,
4H), 6.95 (s, 2H), 4.68 (ddd, J = 7.8, 7.5, 7.0 Hz, 2H), 4.18 (ddd,
J = 7.8, 7.25, 7.0 Hz, 2H), 4.14 (p, J = 7.5 Hz, 2H), 2.95 (dd,
J = 14.5, 7.5 Hz, 2H), 1.78 (s, 6H), 1.51 (m, 2H), 1.28 (t, J = 7.5
Hz, 4H), 1.11 (d, J = 7.0 Hz, 6H), 0.81 (d, J = 6.5 Hz, 6H), 0.76
(d, J = 6.5 Hz, 6H) (2H are overlapping with water between 3.27
and 3.37 ppm); 13C NMR (125 MHz, DMSO-d6) N 174.2, 172.4,
171.2, 169.8, 136.2, 127.9, 187.8, 121.7, 119.2, 118.8, 111.3, 109.5,
53.5, 51.4, 48.2, 40.4, 27.3, 24.1, 22.9, 22.4, 21.5, 18.2; LRMS
(FAB) m/z (intensity %): 901 (8) [M3H+2Na], 889 (72)
[M+Na], 873 (24), 856 (100); HRMS (FAB): calcd for
C44H60N10O8, 856.4595; found 856.4589.
5.4.6. Ditryptophan peptide dimer [AcNH-Leu-Trp*-Ala-NMe2]2,
2b
AcNH-Leu-Trp-Ala-NMe2 2a (0.143 g, 0.314 mmol) was dis-
solved in TFA (1 ml) and stirred at room temperature for 25 h to
e¡ect Mannich crosslinking of the tryptophan sidechains. The
tri£uoroacetic acid was removed under reduced pressure. The
residue was dissolved in CH2Cl2 (1 ml) and cooled to 0‡C. Tri-
ethylamine (1 ml) was slowly introduced and the solution was
stirred for 2 h. The solvent was evaporated in vacuo, and the
remaining starting material was separated from the crude trypto-
phan dimer (77.2 mg) by silica gel chromatography (4.5% MeOH/
CHCl3).
In a pyrex round-bottom £ask open to air, the crude trypto-
phan dimer was dissolved in a solution of 10% THF/CH2Cl2 (32
ml). The reaction mixture was illuminated with a 150 W light
bulb while stirring vigorously for 24 h. The reaction mixture
was concentrated in vacuo, and the residue was puri¢ed via silica
gel chromatography (5% MeOH/CHCl3) to a¡ord ditryptophan
peptide dimer 2b (69.2 mg, 48%) as a solid.
2b : mp 287‡C (CHCl3, dec); Rf = 0.27 (10% MeOH/CHCl3);
IR (CDCl3) 3416, 3343, 2923, 2856, 1635, 1499 cm31 ; 1H NMR
(400 MHz, DMSO-d6) N 11.23 (s, 2H), 8.15 (d, J = 8.0 Hz, 2H),
7.97 (d, J = 8.0 Hz, 2H), 7.94 (d, J = 8.0 Hz, 2H), 7.86 (d, J = 7.6
Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 7.13 (t, J = 6.8 Hz, 2H), 7.03 (t,
J = 7.2 Hz, 2H), 4.70 (q, J = 7.2 Hz, 2H), 4.54 (p, J = 6.8 Hz, 2H),
4.25 (ddd J = 9.6, 8.4, 7.6 Hz, 2H), 2.90 (m, 4H), 2.69 (s, 6H),
2.66 (s, 6H), 1.79 (s, 6H), 1.51 (m, 2H), 1.29 (t, J = 7.6 Hz, 4H),
1.04 (d, J = 6.8 Hz, 6H), 0.82 (d, J = 6.8 Hz, 6H), 0.78 (d, J = 6.8
Hz, 6H); 13C NMR (125 MHz, DMSO-d6) N 172.2, 170.6, 169.3,
136.1, 127.9, 127.8, 121.5, 119.0, 118.7, 111.2, 109.4, 53.5, 51.0,
44.6, 40.6, 36.0, 35.2, 37.5, 24.1, 23.0, 22.4, 21.8, 17.5 (one car-
bonyl peak missing between 167 and 175 ppm); LRMS (FAB) m/
z (intensity %): 913 (78) [M+H], 585 (10), 297 (24), 269 (100),
154 (10), 128 (24); HRMS (FAB): calcd for C48H68N10O8,
935.5119 [M+Na] ; found 935.5119.
5.4.7. Ditryptophan peptide dimer [AcNH-Leu-Trp*-Ala-OMe]2,
3b
AcNH-Leu-Trp-Ala-OMe 3a (0.310 g, 0.700 mmol) was dis-
solved in tri£uoroacetic acid (4.5 ml) and stirred at room temper-
ature for 24 h. The reaction mixture was concentrated in vacuo.
The residue was dissolved in ethyl acetate (50 ml) and washed
with NaHCO3 (3U25 ml) and brine (50 ml). The organic layer
was dried over MgSO4 and concentrated in vacuo. Puri¢cation
via chromatography on silica gel (2.5% MeOH/CHCl3) a¡orded a
diastereomeric mixture of tryptophan dimers as a light-yellow
solid. This mixture of diastereomers was dissolved in dry dioxane
(3 ml) and DDQ (0.077 g, 0.34 mmol) was added and the mixture
was stirred for 5 min at room temperature. Solvent was removed
in vacuo, and the resulting brown solid was dissolved in ethyl
acetate and the dihydroquinone was removed by repeated extrac-
tion with saturated NaHCO3 until the aqueous layer remained
colorless. The organic layer was dried over MgSO4 and concen-
trated in vacuo to a¡ord the crude ditryptophan peptide dimer.
Chromatography on silica gel (2.5% MeOH/CHCl3) a¡orded 3b
(0.130 g, 42%). Dimer 3b was recrystallized from 20% MeOH/
CH2Cl2 at room temperature for X-ray analysis.
3b : 297^298‡C; Rf = 0.36 (10% MeOH/CHCl3); IR (KBr)
3386, 3268, 2948, 1743, 1635, 1524, 1449, 1381, 1339, 1212,
1156, 746 cm31 ; 1H NMR (400 MHz, DMSO-d6) N 11.16 (s,
1H), 8.27 (d, J = 6.7 Hz, 1H), 7.97 (dd, J = 15.6, 7.9 Hz, 1H),
7.76 (d, J = 7.9 Hz, 1H), 7.36 (d, J = 7.9 Hz, 1H), 7.13 (t,
J = 7.0 Hz, 1H), 7.03 (t, J = 7.6 Hz, 1H), 4.72 (dd, J = 14.0, 7.6
Hz, 1H), 4.19 (m, 2H), 3.38 (m, 1H), 3.36 (s, 3H), 2.94 (dd,
J = 14.0, 7.0 Hz, 1H), 1.78 (s, 3H), 1.49 (m, 1H), 1.14 (d,
J = 6.8 Hz, 3H), 0.79 (d, J = 6.0 Hz, 3H), 0.74 (d, J = 6.4 Hz,
3H); 13C NMR (125 MHz, DMSO-d6) N 172.4, 172.1, 171.6,
169.6, 136.2, 128.0, 127.9, 121.6, 119.2, 118.7, 111.2, 109.2,
53.2, 51.7, 51.3, 47.7, 40.4, 27.6, 24.1, 22.9, 22.4, 21.5, 16.8;
LRMS (FAB), m/z (intensity %): 887 (100), 732 (20), 572 (60),
400 (10), 261 (100); HRMS (FAB): calcd for C46H62N8O9,
886.4589; found 886.4576.
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